Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy

Go back to Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy
(NASDAQ: RANI) Delayed: 0.77 -0.01 (1.28%)
Previous Close $0.78    52 Week High
Open $0.78    52 Week Low
Day High $0.83    P/E N/A 
Day Low $0.77    EPS
Volume 609,541